Therefore, it is reasonable to speculate that CASP4 may be one of the factors in the synergistic regulatory network of KRAS and P53 and promoted the biosynthesis of fatty acids in pancreatic cancer and reserves productive substrates for the proliferation and migration of tumor cells in addition to the occurrence of pyroptosis. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.